• 4570 Citations
  • 30 h-Index
1991 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Cheng-Yuan Peng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Chronic Hepatitis B Medicine & Life Sciences
Hepatitis B e Antigens Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Interferons Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

1 Citation (Scopus)
Hepatitis B e Antigens
Chronic Hepatitis B
Interferons
Therapeutics
entecavir
2 Citations (Scopus)

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions

Yu, M. L., Hung, C. H., Huang, Y. H., Peng, C. Y., Lin, C. Y., Cheng, P. N., Chien, R. N., Hsu, S. J., Liu, C. H., Huang, C. F., Su, C. W., Huang, J. F., Liu, C. J., Kao, J. H., Chuang, W. L., Chen, P. J. & Chen, D. S., Feb 2019, In : Journal of the Formosan Medical Association. 118, 2, p. 556-564 9 p.

Research output: Contribution to journalArticle

Ribavirin
Genotype
Safety
Infection
Galectin 3
2 Citations (Scopus)

Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder

Su, K. P., Lai, H-C., Peng, C-Y., Su, W-P., Chang, J. P. C. & Pariante, C. M., Aug 1 2019, In : Brain, behavior, and immunity. 80, p. 512-518 7 p.

Research output: Contribution to journalArticle

Major Depressive Disorder
Interferon-alpha
Depression
Hepacivirus
Research Design

Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant data

Pavlovic, V., Yang, L., Chan, H. L. Y., Hou, J., Janssen, H. L., Kao, J. H., Lampertico, P., Peng, C-Y., Piratvisuth, T., Thompson, A. J., Wedemeyer, H., Wei, L. & Wat, C., Jan 1 2019, In : Antiviral therapy. 24, 2, p. 133-140 8 p.

Research output: Contribution to journalArticle

Hepatitis B e Antigens
Chronic Hepatitis B
Meta-Analysis
Hepatitis B Surface Antigens
Genotype
1 Citation (Scopus)

Proton pump inhibitors increase the risk of cholecystitis: A population-based case-control study

Chuang, S. C., Lin, C. C., Peng, C-Y., Huang, W-H., Su, W-P., Lai, S. W. & Lai, H-C., Jul 1 2019, In : Gut. 68, 7, p. 1337-1339 3 p.

Research output: Contribution to journalLetter

Cholecystitis
Proton Pump Inhibitors
Case-Control Studies
Population